ArticleJournal of Cancer2021

Combination of oncolytic adenovirus targeting SATB1 and docetaxel for the treatment of castration-resistant prostate cancer.

Lijun Mao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.